Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S4-E23.1 - Obeticholic Acid: Is the Juice Worth the Squeeze?
Description: Stephen Harrison joins Louise Campbell and Roger Green for an insight-laden episode about challenges and opportunities in NASH drug development. This first conversation begins with an update from Stephen on what he has been working on since last appearing on the podcast. He notes new and exciting data emerging from NGM on aldafermin, an FGF19, which indicates that multiple different mechanisms are demonstrating a positive impact on cirrhosis. Stephen shares that he is “becoming more convinced that we can move the needle in this toughest to treat patient population, albeit prior to them developing decompensating disease. There is hope th...